Read-Gene Overview
- Founded
-
2005
- Status
-
Public
- Employees
-
23
- Stock Symbol
-
RDG
- Share Price
-
$0.45
- (As of Tuesday Closing)
Read-Gene General Information
Description
Read-Gene SA treats each patient individually based on genetic tests. The company's segments include chemoprevention, clinical trials and genetic tests. It also engaged in developing technologies to commercialize methods to detect, prevent and treat malignant tumours.
Contact Information
Primary Industry
Other Healthcare Technology Systems
Other Industries
Biotechnology
Stock Exchange
WAR
Primary Office
- Ul. Alabastrowa 8
- Grzepnica, 72-003
- Poland
+48 91 000 00 00
Read-Gene Stock Performance
(As of Tuesday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.45 | $0.47 | $0.39 - $0.80 | $5.58M | 11.8M | 2.1K |
Read-Gene Financials Summary
|
In Thousands, USD |
TTM 30-Jun-2022 | FY 2021 31-Dec-2021 | FY 2020 31-Dec-2020 | FY 2019 31-Dec-2019 |
|---|---|---|---|---|
| EV | 4,569 | 6,487 | 6,641 | 1,013 |
| Revenue | 1,715 | 1,671 | 1,556 | 1,658 |
| EBITDA | 133 | 174 | 296 | 427 |
| Net Income | (10) | 10 | 90 | 31 |
| Total Assets | 3,335 | 3,792 | 4,347 | 4,279 |
| Total Debt | 0 | 1,396 | 1,532 | 0 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Read-Gene Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
